When was Ology Bio founded?

Ology Bio was founded in 1999 and raised its 1st funding round 6 years after it was founded.

Where is Ology Bio located?

Ology Bio is headquartered in Alachua, United States.

How many employees does Ology Bio have?

As of Jan 31, 2026, the latest employee count at Ology Bio is 185.

Is Ology Bio a funded company?

Ology Bio is a funded company, having raised an undisclosed amount across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2005.

When was the latest funding round of Ology Bio?

Ology Bio's latest funding was a $***** Grant (prize money) round on Aug 2018, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $297M in funding in 2026 to date.

Where does Ology Bio rank among its competitors?

Ology Bio ranks 31st amongst 306 active competitors, of which 18 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Ology Bio?

Ology Bio's top competitors include Anthem Biosciences, Patheon and Abzena. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Ology Bio - 2026 Company Profile, Funding & Competitors

Company Details

Ology Bioservices (formerly Nanotherapeutics) is a biologics-focused contract development and manufacturing organization (CDMO) serving both government and commercial clients. It offers services such as process development, cell line development, cGMP manufacturing, analytical & regulatory for recombinant proteins, monoclonal antibodies, viral vaccines, and gene therapy drug products. The company has developed proprietary vaccine delivery technologies and platform expression systems. The company uses their proprietary Vero Cell vaccine manufacturing cell line acquired from Baxalta/Baxter Vaccines for the development of inactivated whole virus vaccines. It offers mammalian cell line development capabilities. The company has a BSL-3 & cGMP compliant vaccines manufacturing facility called Advanced Development and Manufacturing (ADM) facility. The company has several vaccine programs available for partnering and/or licensing such as ross river (phase III), chikungunya, pandemic and seasonal flu vaccines, yellow fever (MVA), typhoid, West Nile and norovirus.

Website: www.ologybio.com
Social
Email ID: *****@ologybio.com
Phone Number: +1 **********

Key Metrics

Founded Year

1999

Location

Alachua, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Aug 2018, $*****

Investors

Trinity Capital & 7 more

Ranked

31^st among 306 active competitors

Employee Count

185 as on Jan 31, 2026

Similar Companies

KBI Biopharma & 156 more

Exit Details

Acquired by Resilience (Apr 12, 2021)

View Ology Bio's full profile

Ology Bio got acquired by Resilience on Apr 12, 2021.

Click here to take a look at Ology Bio's acquisition in detail

Ology Bio has raised funding over 7 rounds. Its first funding round was on 2005. Its latest funding round was a Grant (prize money) round on Aug 2018 for $*****. 1 investor participated in its latest round. Ology Bio has 8 institutional investors.

Here is the list of recent funding rounds of Ology Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 2018	9895598	Grant (prize money)	2148605	9941481	5939686	3706976
Mar 28, 2018	7222375	PE	9277500	2468579	3459337	GHIT Fund
Mar 17, 2015	6168467	Conventional Debt	6905334	3552467	4655729	White Oak Global Advisors

Access funding benchmarks and valuations. Sign up today!

View details of Ology Bio's funding rounds and investors

Ology Bio's employee count trend

Ology Bio has 185 employees as of Jan 26. Here is Ology Bio's employee count trend over the years:

Uncover Ology Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ology Bio include Anthem Biosciences, Patheon and Abzena. Here is the list of Top 10 competitors of Ology Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2007, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 7 others	77/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	JLL Partners, Frazier Healthcare Partners ... & 3 others	75/100
3rd	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	69/100
4th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	68/100
5th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	68/100
6th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, ADIA & 8 others	66/100
7th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 4 others	63/100
8th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	62/100
9th	Maravai Life Sciences 2014, San Diego (United States), Public	Provides enabling tools and services in the life sciences research and bio-production industries	-	HTIF, GTCR	60/100
10th	Piramal Pharma Solutions 1988, Mumbai (India), Unfunded	Contract manufacturer of pharmaceutical products	-	-	60/100
31st	Ology Bio 1999, Alachua (United States), Acquired	Biologics-focused contract development and manufacturing organization (CDMO)	-	Trinity Capital, Hercules Capital & 6 others	47/100